These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 24619503)
1. MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview. Henriksen M; Johnsen KB; Andersen HH; Pilgaard L; Duroux M Mol Neurobiol; 2014 Dec; 50(3):896-913. PubMed ID: 24619503 [TBL] [Abstract][Full Text] [Related]
2. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures. Yerukala Sathipati S; Huang HL; Ho SY BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650 [TBL] [Abstract][Full Text] [Related]
3. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872 [TBL] [Abstract][Full Text] [Related]
4. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Møller HG; Rasmussen AP; Andersen HH; Johnsen KB; Henriksen M; Duroux M Mol Neurobiol; 2013 Feb; 47(1):131-44. PubMed ID: 23054677 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme. Henriksen M; Johnsen KB; Olesen P; Pilgaard L; Duroux M Neuromolecular Med; 2014 Sep; 16(3):565-77. PubMed ID: 24817689 [TBL] [Abstract][Full Text] [Related]
6. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients. Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437 [TBL] [Abstract][Full Text] [Related]
7. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review. Ahir BK; Ozer H; Engelhard HH; Lakka SS Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335 [TBL] [Abstract][Full Text] [Related]
9. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin. Herman A; Gruden K; Blejec A; Podpečan V; Motaln H; Rožman P; Hren M; Zupančič K; Veber M; Verbovšek U; Lah Turnšek T; Porčnik A; Koršič M; Knežević M; Jeras M PLoS One; 2015; 10(5):e0125791. PubMed ID: 25950799 [TBL] [Abstract][Full Text] [Related]
10. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes. Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456 [TBL] [Abstract][Full Text] [Related]
11. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer. Fatai AA; Gamieldien J BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978 [TBL] [Abstract][Full Text] [Related]
12. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells. C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939 [TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p. Jiang G; Dong H; Dong Y; Yang X Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416 [TBL] [Abstract][Full Text] [Related]
14. Identify signature regulatory network for glioblastoma prognosis by integrative mRNA and miRNA co-expression analysis. Bing ZT; Yang GH; Xiong J; Guo L; Yang L IET Syst Biol; 2016 Dec; 10(6):244-251. PubMed ID: 27879479 [TBL] [Abstract][Full Text] [Related]
15. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
16. Identifying dysfunctional miRNA-mRNA regulatory modules by inverse activation, cofunction, and high interconnection of target genes: a case study of glioblastoma. Xiao Y; Ping Y; Fan H; Xu C; Guan J; Zhao H; Li Y; Lv Y; Jin Y; Wang L; Li X Neuro Oncol; 2013 Jul; 15(7):818-28. PubMed ID: 23516263 [TBL] [Abstract][Full Text] [Related]
17. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells. Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270 [TBL] [Abstract][Full Text] [Related]
18. Recent advances of the regulation roles of MicroRNA in glioblastoma. Yan C; Kong X; Gong S; Liu F; Zhao Y Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433 [TBL] [Abstract][Full Text] [Related]
19. The Influence of Distinct Regulatory miRNAs of the p15/p16/RB1/E2F Pathway on the Clinical Progression of Glioblastoma Multiforme. Sippl C; Teping F; Ketter R; Braun L; Tremmel L; Schulz-Schaeffer W; Oertel J; Urbschat S World Neurosurg; 2019 Dec; 132():e900-e908. PubMed ID: 31351207 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Shea A; Harish V; Afzal Z; Chijioke J; Kedir H; Dusmatova S; Roy A; Ramalinga M; Harris B; Blancato J; Verma M; Kumar D Cancer Med; 2016 Aug; 5(8):1917-46. PubMed ID: 27282910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]